A new trial at Sheffield Children's Hospital will test whether a combined inhaler can better control asthma symptoms and attacks in youngsters. The study, which focuses on children aged six to 11, ...

Some pediatricians say they’ve seen an increase in asthma-related hospitalizations and deaths. Families are facing drug shortages and increased costs as they try to get the inhalers their children ...

These new findings may help shape both the design and the use of an educational intervention on technology-based inhaler techniques for patients with pediatric asthma. These results were the product ...

Add Yahoo as a preferred source to see more of our stories on Google. More children stopped using steroid inhalers to control their asthma after GlaxoSmithKline withdrew Flovent from the market. Adobe ...

BRAWLEY — Imperial Valley Healthcare District (IVHD) is encouraging parents and caregivers to take a proactive approach to childhood asthma management, especially as seasonal and environmental ...

For many children, asthma can be a constant specter, with attacks at the most inconvenient and terrifying times. New research has now found that one inhaler containing two drugs can cut the risk of ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...

Respiratory consultant emphasises the importance of personalised action plans to manage symptoms, while community care brings ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.

A new study found that a 2-in-1 anti-inflammatory inhaler reduced asthma attacks in children by 45% compared to the widely-used salbutamol inhaler. The corresponding study was published in The Lancet.